XRF SCIENTIFIC LIMITED (XRF)
Latest AI Signal: SELL
Status: EXPIRED
Days Old: 58
Confidence: 75.00%
Date: 24-03-2026
Price: $1.625
Last Price: $1.710
Post-Signal Low Price: $1.635
Latest XRF SCIENTIFIC LIMITED(XRF) News
29 Jan 2026, 02:05 PM
As Australian shares experience a relatively flat start following the U.S. Federal Reserve's decision to hold rates steady and a surprise inflation hike, investors are cautiously eyeing the market for clearer signals. Amidst this climate of uncertainty, penny stocks—despite their somewhat outdated m
25 Aug 2025, 06:02 AM
As the ASX 200 hovers just above 9,000 points, traders are cautiously navigating the market amid global economic events and local earnings reports. Despite some hesitancy, certain smaller stocks continue to capture investor attention due to their potential for growth and value. Penny stocks, though
Sell Confidence High
AI Confidence - 75.00 % model confidence
Business Overview
XRF Scientific Limited specializes in the design, manufacture, and distribution of advanced X-ray fluorescence (XRF) analytical instruments used for material analysis in mining, environmental, and industrial sectors. The company holds a niche market position with a strong focus on innovation and servicing global mining and exploration clients.
Financial Analysis
| Cash Flow | Weak |
| Debt | Moderate |
| Profitability | Weak |
| Revenue Trend | Downtrend |
Technical Analysis
| Trend | Bearish |
| Momentum | Weak |
| RSI Signal | Oversold |
| Support Level | $ 1.50 |
| Resistance Level | $ 1.80 |
Valuation
Valuation - Overvalued
Current price reflects stretched multiples despite weakening fundamentals and declining revenue.
Catalysts
• Potential contract wins in mining sector could stabilize revenue.
• New product launches improving competitive positioning.
• Cost reduction initiatives to improve margins.
Recommendation
Action - Sell
Timeframe - Short Term
Given the declining revenue trend, weak profitability, and bearish technical signals, XRF Scientific appears overvalued at current levels. The stock faces near-term downside risk amid sector volatility and financial weakness.